亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

Topiramate (97240-79-4)

 
 
單價 面議對比
詢價 暫無
發貨 陜西西安市預售,付款后5天內
庫存 1000KG起訂1KG
品牌 DSTECH
型號 97240-79-4
規格 USP 32
過期 長期有效
更新 2011-06-07 15:33
 

Shaanxi Dasheng Chemical Tech Co., Ltd.

企業會員第15年
資料未認證
保證金未繳納
詳細說明

1. CAS RN:  97240-79-4
2. Structural Formula:         
3. Molecular formula & Molecular weight: C12H21NO8S        339.37
4. Appearance: It’s a white to off-white powder. Freely soluble in dichloromethane
5. Quality Standard:  USP32,  purity  ≥ 98.0%
 Identification Infrared Absorption
 The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation , as obtained in the Assay
Specific rotation Between -28.6° and -35.0°,measured at 20°
Water Not more than 0.5%
Residue on Ignition Not more than 0.1%
Heavy metals Not more than 10ppm
Related compounds by HPLC
(Test 1) Fructose not more than 0.3%
Compound A not more than 0.3%
Other individual impurity not more than 0.1%
Total impurities not more than 0.5%
Limit of sulfamate and sulfate Sulfamate ion not more than 0.10%;
Sulfate ion not more than 0.10%.
Assay                                                                  Topiramate contains not less than 98.0% and not more than the equivalent of 102.0% of C12H21NO8S, calculated with reference to the Anhydrous Basis.
6. Usage: It’s a new drug of anticonvulsants.
7. Storage: It stored in sealed containers, cool and dry place, and away from light.
8. Packing:  Paper bucket, 25kg/package.
9. HS CODE: 2932 9990.90
舉報收藏 0評論 0
更多>本企業其它產品
Clopidogrel N-Acetylglycine acid DL-N-Acetaminocinnamic Acid Intermediate of Bicalutamide Chlorhexidine Acetate Chlorhexidine Hydrochloride Intermediate of Bicalutamide Intermediate of Bicalutamide
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |